Joshua Ruch's most recent trade in GeneDx Holdings Corp - Ordinary Shares - Class A was a trade of 11,234 Class A Common Stock done at an average price of $161.2 . Disclosure was reported to the exchange on Nov. 24, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| GeneDx Holdings Corp (Class A) | Joshua Ruch | Director | Sale of securities on an exchange or to another person at price $ 161.16 per share. | 24 Nov 2025 | 11,234 | 120,811 | - | 161.2 | 1,810,437 | Class A Common Stock |
| GeneDx Holdings Corp (Class A) | Joshua Ruch | Director | Sale of securities on an exchange or to another person at price $ 160.45 per share. | 24 Nov 2025 | 8,944 | 132,045 | - | 160.4 | 1,435,059 | Class A Common Stock |
| GeneDx Holdings Corp (Class A) | Joshua Ruch | Director | Sale of securities on an exchange or to another person at price $ 159.28 per share. | 24 Nov 2025 | 6,279 | 140,989 | - | 159.3 | 1,000,093 | Class A Common Stock |
| GeneDx Holdings Corp (Class A) | Joshua Ruch | Director | Sale of securities on an exchange or to another person at price $ 161.16 per share. | 24 Nov 2025 | 2,268 | 24,390 | - | 161.2 | 365,504 | Class A Common Stock |
| GeneDx Holdings Corp (Class A) | Joshua Ruch | Director | Sale of securities on an exchange or to another person at price $ 158.40 per share. | 24 Nov 2025 | 2,016 | 147,268 | - | 158.4 | 319,342 | Class A Common Stock |
| GeneDx Holdings Corp (Class A) | Joshua Ruch | Director | Sale of securities on an exchange or to another person at price $ 160.45 per share. | 24 Nov 2025 | 1,805 | 26,658 | - | 160.4 | 289,611 | Class A Common Stock |
| GeneDx Holdings Corp (Class A) | Joshua Ruch | Director | Sale of securities on an exchange or to another person at price $ 159.28 per share. | 24 Nov 2025 | 1,268 | 28,463 | - | 159.3 | 201,962 | Class A Common Stock |
| GeneDx Holdings Corp (Class A) | Joshua Ruch | Director | Sale of securities on an exchange or to another person at price $ 161.16 per share. | 24 Nov 2025 | 1,117 | 12,013 | - | 161.2 | 180,012 | Class A Common Stock |
| GeneDx Holdings Corp (Class A) | Joshua Ruch | Director | Sale of securities on an exchange or to another person at price $ 160.45 per share. | 24 Nov 2025 | 889 | 13,130 | - | 160.4 | 142,640 | Class A Common Stock |
| GeneDx Holdings Corp (Class A) | Joshua Ruch | Director | Sale of securities on an exchange or to another person at price $ 162.04 per share. | 24 Nov 2025 | 728 | 120,083 | - | 162.0 | 117,964 | Class A Common Stock |
| GeneDx Holdings Corp (Class A) | Joshua Ruch | Director | Sale of securities on an exchange or to another person at price $ 159.28 per share. | 24 Nov 2025 | 625 | 14,019 | - | 159.3 | 99,547 | Class A Common Stock |
| GeneDx Holdings Corp (Class A) | Joshua Ruch | Director | Sale of securities on an exchange or to another person at price $ 158.40 per share. | 24 Nov 2025 | 407 | 29,731 | - | 158.4 | 64,470 | Class A Common Stock |
| GeneDx Holdings Corp (Class A) | Joshua Ruch | Director | Sale of securities on an exchange or to another person at price $ 158.40 per share. | 24 Nov 2025 | 201 | 14,644 | - | 158.4 | 31,839 | Class A Common Stock |
| GeneDx Holdings Corp (Class A) | Joshua Ruch | Director | Sale of securities on an exchange or to another person at price $ 162.04 per share. | 24 Nov 2025 | 147 | 24,243 | - | 162.0 | 23,820 | Class A Common Stock |
| GeneDx Holdings Corp (Class A) | Joshua Ruch | Director | Sale of securities on an exchange or to another person at price $ 162.04 per share. | 24 Nov 2025 | 72 | 11,941 | - | 162.0 | 11,667 | Class A Common Stock |
| GeneDx Holdings Corp (Class A) | Joshua Ruch | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Jun 2025 | 12,924 | 29,723 | - | 0 | Class A Common Stock | |
| GeneDx Holdings Corp (Class A) | Joshua Ruch | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Jun 2025 | 12,924 | 0 | - | - | Restricted Stock Unit | |
| GeneDx Holdings Corp (Class A) | Joshua Ruch | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2025 | 3,576 | 3,576 | - | - | Restricted Stock Unit | |
| GeneDx Holdings Corp (Class A) | Joshua Ruch | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.89 per share. | 05 Feb 2025 | 5,816 | 16,799 | - | 7.9 | 45,888 | Class A Common Stock |
| GeneDx Holdings Corp (Class A) | Joshua Ruch | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Feb 2025 | 5,816 | 0 | - | - | Stock Option (right to buy) | |
| GeneDx Holdings Corp (Class A) | Joshua Ruch | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jan 2025 | 3,000 | 5,816 | - | - | Stock Option (right to buy) | |
| GeneDx Holdings Corp (Class A) | Joshua Ruch | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.89 per share. | 17 Jan 2025 | 3,000 | 10,983 | - | 7.9 | 23,670 | Class A Common Stock |
| GeneDx Holdings Corp (Class A) | Joshua Ruch | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Oct 2024 | 130 | 0 | - | - | Restricted Stock Unit | |
| GeneDx Holdings Corp (Class A) | Joshua Ruch | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Oct 2024 | 130 | 7,983 | - | - | Class A Common Stock | |
| GeneDx Holdings Corp (Class A) | Joshua Ruch | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jun 2024 | 12,924 | 12,924 | - | - | Restricted Stock Unit | |
| GeneDx Holdings Corp (Class A) | Joshua Ruch | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jun 2024 | 5,828 | 7,853 | - | 0 | Class A Common Stock | |
| GeneDx Holdings Corp (Class A) | Joshua Ruch | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jun 2024 | 5,828 | 0 | - | - | Restricted Stock Unit | |
| GeneDx Holdings Corp (Class A) | Joshua Ruch | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Oct 2023 | 129 | 2,025 | - | - | Class A Common Stock | |
| GeneDx Holdings Corp (Class A) | Joshua Ruch | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Oct 2023 | 129 | 130 | - | - | Restricted Stock Unit | |
| GeneDx Holdings Corp (Class A) | Joshua Ruch | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jul 2023 | 8,816 | 8,816 | - | - | Stock Option (Right to Buy) | |
| GeneDx Holdings Corp (Class A) | Joshua Ruch | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jul 2023 | 5,828 | 5,828 | - | - | Restricted Stock Unit | |
| GeneDx Holdings Corp (Class A) | Joshua Ruch | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 May 2023 | 45,454 | 62,568 | - | 0 | Class A Common Stock | |
| GeneDx Holdings Corp (Class A) | Joshua Ruch | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 May 2023 | 45,454 | 0 | - | - | Restricted Stock Unit | |
| GeneDx Holdings Corp (Class A) | Joshua Ruch | Director | Grant, award, or other acquisition of securities at price $ 0.35 per share. | 27 Jan 2023 | 3,293,371 | 4,926,334 | - | 0.4 | 1,152,680 | Class A Common Stock |
| GeneDx Holdings Corp (Class A) | Joshua Ruch | Director | Grant, award, or other acquisition of securities at price $ 0.35 per share. | 27 Jan 2023 | 664,869 | 994,534 | - | 0.3 | 232,704 | Class A Common Stock |
| GeneDx Holdings Corp (Class A) | Joshua Ruch | Director | Grant, award, or other acquisition of securities at price $ 0.35 per share. | 27 Jan 2023 | 327,474 | 489,846 | - | 0.4 | 114,616 | Class A Common Stock |
| GeneDx Holdings Corp (Class A) | Joshua Ruch | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Oct 2022 | 4,278 | 17,114 | - | - | Class A Common Stock | |
| GeneDx Holdings Corp (Class A) | Joshua Ruch | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Oct 2022 | 4,278 | 8,558 | - | - | Restricted Stock Unit | |
| GeneDx Holdings Corp (Class A) | Joshua Ruch | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 May 2022 | 78,914 | 78,914 | - | - | Stock Option | |
| GeneDx Holdings Corp (Class A) | Joshua Ruch | Director | Grant, award, or other acquisition of securities at price $ 4.00 per share. | 29 Apr 2022 | 1,632,963 | 1,632,963 | - | 4 | 6,531,852 | Class A Common Stock |
| GeneDx Holdings Corp (Class A) | Joshua Ruch | Director | Grant, award, or other acquisition of securities at price $ 4.00 per share. | 29 Apr 2022 | 329,665 | 329,665 | - | 4 | 1,318,660 | Class A Common Stock |
| GeneDx Holdings Corp (Class A) | Joshua Ruch | Director | Grant, award, or other acquisition of securities at price $ 4.00 per share. | 29 Apr 2022 | 162,372 | 162,372 | - | 4 | 649,488 | Class A Common Stock |
| GeneDx Holdings Corp (Class A) | Joshua Ruch | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Apr 2022 | 12,836 | 0 | - | - | Restricted Stock Unit | |
| GeneDx Holdings Corp (Class A) | Joshua Ruch | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Apr 2022 | 12,836 | 12,836 | - | - | Class A Common Stock | |
| GeneDx Holdings Corp (Class A) | Joshua Ruch | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Oct 2021 | 22,286 | 22,286 | - | - | Employee Stock Option (Right to Buy) | |
| GeneDx Holdings Corp (Class A) | Joshua Ruch | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Oct 2021 | 22,286 | 22,286 | - | - | Employee Stock Option (Right to Buy) | |
| GeneDx Holdings Corp (Class A) | Joshua Ruch | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Oct 2021 | 12,836 | 12,836 | - | - | Restricted Stock Unit | |
| GeneDx Holdings Corp (Class A) | Joshua Ruch | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Oct 2021 | 12,836 | 12,836 | - | - | Restricted Stock Unit |